New Delhi, July 9 -- Chennai-based Iswarya Fertility Center has raised more than Rs.350 crore (nearly $37 million) in a growth investment from healthcare investment firm OrbiMed Asia, as investors increase their focus on India's expanding fertility care market amid shifting demographic trends.

The funding will help Iswarya establish new centres in existing and underserved markets, strengthen clinical infrastructure, invest in digital capabilities and expand its embryology talent pipeline, the company said in a statement on Thursday.

"Our focus over the next phase is clear: deepen our pan-India presence, enter underserved geographies and keep raising the bar on clinical outcomes," Dr. Arun Muthuvel, managing director at Iswarya Fertility...